Charles Schwab Investment Management Inc Sc Pharmaceuticals Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 94,809 shares of SCPH stock, worth $537,567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
94,809
Previous 105,935
10.5%
Holding current value
$537,567
Previous $278,000
29.86%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SCPH
# of Institutions
100Shares Held
36.5MCall Options Held
757KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA6.06MShares$34.4 Million0.82% of portfolio
-
Rubric Capital Management LP New York, NY4.6MShares$26.1 Million0.4% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.87MShares$21.9 Million8.33% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX3.54MShares$20.1 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.15MShares$12.2 Million0.0% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $155M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...